Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAICAT: Adjuvant HAIC in HCC
NCT02767375Phase 3Unknown
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Feb 2015
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil in hepatocellular carcinoma (HCC), sponsored by Peking University Cancer Hospital & Institute. Status: unknown.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02767375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767375.